NovoLog® (insulin aspart [rDNA origin] injection) is a fast-acting mealtime insulin that may help you control your high blood sugar. NovoLog® is a man-made insulin that is used to control high blood sugar in adults and children with diabetes mellitus. Side effects may occur. See Important Safety Information.
| Website | http://www.novolog.com |
| Revenue | $5 million |
| Employees | View employees |
| Competitors | Dexcom, Medtronic Diabetes, Glooko, CareLink Business Hosting, Accu-Chek, Lantus, Jardiance, Basaglar, Trulicity +16 more (view full list) |
Looking for a particular NovoLog employee's phone or email?
NovoLog Questions
The NovoLog annual revenue was $5 million in 2026.
G2Crowd Trusted
300K+
Plugin Users
